NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

CompletedPhase 4

Sponsor: Stiefel, a GSK Company

Conditions: Hand Dermatosis

Interventions: clobetasol propionate

Countries: United States

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions.
* Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception

Exclusion Criteria:

* Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit.
* Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit

Locations (1)

Louisville, Kentucky, United States